Video
Mark Barricklow, RPh, discusses the challenges associated with centralized compounding parenteral nutrition.
Mark Barricklow, RPh, discusses the challenges associated with centralized compounding parenteral nutrition.
FDA Approves Dupilumab, Marking First Targeted Therapy in a Decade for Chronic Spontaneous Urticaria